Search research articles
Contact Us
Filters
Showing results (221-230 of 236) with videos related to
Page
of 24
Sort By:
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
September 4, 2019
Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement
H Peach, R Board, M Cook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study
G A McArthur, M Maio, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)
T Powles, J Brown, J Larkin, et al.
Journal of the American Medical Directors Association
|
June 15, 2021
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening
David A Nace, Kevin E Kip, John W Mellors, et al.
ESMO Open
|
May 25, 2024
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
I Lugowska, J C Becker, P A Ascierto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2023
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
J M Piulats, C Watkins, M Costa-García, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2024
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Amaral, M Ottaviano, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O Michielin, A van Akkooi, P Lorigan, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 236) with videos related to
Sort By:
Page
of 24
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
September 4, 2019
Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement
H Peach, R Board, M Cook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study
G A McArthur, M Maio, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)
T Powles, J Brown, J Larkin, et al.
Journal of the American Medical Directors Association
|
June 15, 2021
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening
David A Nace, Kevin E Kip, John W Mellors, et al.
ESMO Open
|
May 25, 2024
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
I Lugowska, J C Becker, P A Ascierto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2023
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
J M Piulats, C Watkins, M Costa-García, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2024
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Amaral, M Ottaviano, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O Michielin, A van Akkooi, P Lorigan, et al.
Page
of 24